Janet Fisher to Recombinant Fusion Proteins
This is a "connection" page, showing publications Janet Fisher has written about Recombinant Fusion Proteins.
Connection Strength
0.163
-
ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy. J Immunother Cancer. 2020 04; 8(1).
Score: 0.150
-
Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. J Bone Miner Res. 2004 Nov; 19(11):1873-81.
Score: 0.013